• Humaira Khan kmu


Background: Beta thalassemia syndrome represents a wide spectrum and clinically diverse group of recessively inherited dyserythropoietic anaemias including beta thal-assemia major, beta thalassemia intermedia and beta- thalassemia compound hetero-zygotes. The group is signified by defective synthesis of one or more globin subunits of the hemoglobin tetramer requiring blood transfusions. Human body does not have an internal mechanism to eliminate the surplus iron, thus iron overload and its se-quelae follow, effecting complexion, growth, vital organs, sexual maturity, calcium metabolism and vulnerable endocrine functions.

Objectives: To determine the frequency of hypogonadism in multi-transfused beta thalassemia syndrome patients in Khyber Pakhtunkhwa province of Pakistan.

Materials and Methods: This cross sectional descriptive study included 97 patients, 55 males and 42 females aged 15 to 32 years, regularly transfused at Fatimid foun-dation Hayatabad Peshawar. Patients’ data was recorded in questionnaires. Clini-cal characteristics relevant to growth and puberty were recorded. Serum Ferritin, FSH, LH, Testosterone and Estradiol assays were performed using Chemilumines-ence (CLIA) technique. Data was analyzed by SPSS version 20. Means, standard deviation and frequencies were calculated for numerical variables.

Results: Hypogonadism was seen in 40.2% of the whole population (56.4% in males and 19.04% in females). Amongst 42 females, 32 were above 16 years. 43.7% had primary amenorrhoea while 12.5% had secondary amenorrhoea, with an average age of menarche 16±2 years. Delayed puberty was observed in 54.7% of females and 83.6% of males

Conclusion: Delayed puberty and hypogonadism are obvious endocrinopathies showing higher frequencies in iron overloaded thalassemic patients of Khyber Pakhtunkhwa. In this study, frequency of hypogonadism was found more in males as compared to females. Regular endocrine evaluation and timely in-tervention can ensure sexual maturity and improved quality of life for these patients.



Galanello R, Origa R. Review: Beta-thalassemia. Orphanet J Rare Dis. 2010;5(11).

Olivieri NF. The β-thalassemias. New England Journal of

Medicine. 1999;341(2):99-109.

Flint J, Harding RM, Boyce AJ, Clegg JB. 1 The population genetics of the haemoglobinopathies. Baillière’s clinical haematology. 1998;11(1):1-51.

Cappellini M-D, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the clinical management of thalas-saemia: Thalassaemia International Federation, Nicosia (CY); 2008.

Adil A, Sobani ZA, Jabbar A, Adil SN, Awan S. Endocrine complications in patients of beta thalassemia major in a tertiary care hospital in Pakistan. Journal of the Pakistan Medical Association. 2012;62(3):307.

Srivatsa A, Marwaha R, Muraldharan R, Trehan A. Assess-ment of adrenal endocrine function in Asian thalassemics. Indian Pediatr. 2005;42(1):31-5.

Karamifar H, Shahriari M, Sadjadian N. Prevalence of en-docrine complications in beta-thalassaemia major in the Islamic Republic of Iran. Eastern Mediterranean health journal. 2002;9(1-2):55-60.

Al-Elq AH, Al-Saeed HH. Endocrinopathies in patients with thalassemias. Saudi medical journal. 2004;25(10):1347-51.

Cooley TB, Lee P. A series of cases of splenomegaly in chil-dren with anemia and peculiar bone changes. Trans Am Pediatr Soc. 1925;37(29.1925).

Cappellini MD. Long-term efficacy and safety of defera-sirox. Blood reviews. 2008;22:S35-S41.

Sway Lay Thein, David Rees In: A.Victor Hoffbrand, Daniel Catovsky, Edward G. D. Tuddenham, Green AR, editors. Postgraduate Haematology. 6th ed. London: Wiley-Black-well; 2011. p. 83-108.

Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. Journal of Pediatric Endocrinology and Metabolism. 1997;10(2):175-84.

De Sanctis V. Growth and puberty and its management in thalassaemia. Hormone research. 2001;58:72-9.

Merchant RH, Shirodkar A, Ahmed J. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients. The Indian Journal of Pediatrics. 2011;78(6):679-83.

Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Korn-reich L, et al. Serum ferritin level as a predictor of im-paired growth and puberty in thalassemia major patients. European journal of haematology. 2005;74(2):93-100.

Chen W, Jie W, Chen Z, Jie X, Huang-Xian J. Chemilumi-nescent immunoassay and its applications. Chinese Jour-nal of Analytical Chemistry. 2012;40(1):3-10.

Berkovitch M, Bistritzer T, Milone S, Perlman K, Kucha-rczyk W, Koren G, et al. Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function. Journal of Pediat-ric Endocrinology and Metabolism. 2000;13(2):179-84.

Kattamis C, Liakopoulou T, Kattamis A. Growth and devel-opment in children with thalassaemia major. Acta Paedi-atrica. 1990;79(s366):111-7.

Mirmomen S, Alavian S-M, Hajarizadeh B, Kafaee J, Yek-taparast B, Zahedi M-J, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006;9(4):319-23.

Abdelrazik N, Ghanem H. Failure of puberty in Egyptian beta thalassemic patients: Experience in north east re-gion—Dakahlia province. Hematology. 2007;12(5):449-56.

Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, et al. Increased prevalence of iron‐overload associat-ed endocrinopathy in thalassaemia versus sickle‐cell dis-ease. British journal of haematology. 2006;135(4):574-82.

Toumba M, Kanaris C, Simamonian K, Skordis N. Outcome and management of pregnancy in women with thalassae-mia in Cyprus. Eastern Mediterranean Health Journal. 2008;14:628-35.


How to Cite

Khan, H. (2017). HYPOGONADISM IN MULTIPLY TRANSFUSED β- THALASSEMIA SYNDROME PATIENTS. ADVANCES IN BASIC MEDICAL SCIENCES, 1(2). Retrieved from https://abms.kmu.edu.pk/index.php/abms/article/view/40